ID: ALA5282360

Max Phase: Preclinical

Molecular Formula: C21H16N6OS2

Molecular Weight: 432.53

Associated Items:

Representations

Canonical SMILES:  O=C1/C(=N/Nc2nccs2)C(c2ccccc2)=NN1C1=NC(c2ccccc2)CS1

Standard InChI:  InChI=1S/C21H16N6OS2/c28-19-18(24-25-20-22-11-12-29-20)17(15-9-5-2-6-10-15)26-27(19)21-23-16(13-30-21)14-7-3-1-4-8-14/h1-12,16H,13H2,(H,22,25)/b24-18+

Standard InChI Key:  ATUISHMNSVOAKG-HKOYGPOVSA-N

Associated Targets(Human)

Apoptosis regulator BAX 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 432.53Molecular Weight (Monoisotopic): 432.0827AlogP: 4.00#Rotatable Bonds: 4
Polar Surface Area: 82.31Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.28CX Basic pKa: 2.82CX LogP: 5.84CX LogD: 4.77
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: -1.02

References

1. Pogmore JP, Uehling D, Andrews DW..  (2021)  Pharmacological Targeting of Executioner Proteins: Controlling Life and Death.,  64  (9.0): [PMID:33939407] [10.1021/acs.jmedchem.0c02200]

Source